Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Liver cirrhosis (LC) is an important problem in patients with end-stage renal disease (ESRD). Few studies have investigated the inf luence of LC on mortality in patients with ESRD. This study investigated the association between LC and mortality among patients with ESRD and compare mortality between two dialysis modalities. Methods: Adult patients (≥ 18 years of age) starting dialysis for ESRD were enrolled in the present study from 2000 to 2011. We analyzed 1,069 patients with ESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patients were undergoing peritoneal dialysis (PD). Results: The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-, 3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively, whereas the equivalent survival rates of cirrhotic patients were 90%, 68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independent risk factor for death in patients with ESRD. No difference in mortality associated with LC was found between the HD and PD subgroups. Conclusions: Of the patients with ESRD, cirrhotic patients had poorer survival than noncirrhotic patients. Among patients with ESRD and LC, survival of patients undergoing PD may be comparable with that of patients undergoing H
Abstract
Background/Aims: Liver cirrhosis (LC) is an important problem in patients with end-stage renal disease (ESRD). Few studies have investigated the inf luence of LC on mortality in patients with ESRD. This study investigated the association between LC and mortality among patients with ESRD and compare mortality between two dialysis modalities. Methods: Adult patients (≥ 18 years of age) starting dialysis for ESRD were enrolled in the present study from 2000 to 2011. We analyzed 1,069 patients with ESRD; of these, 742 patients were undergoing hemodialysis (HD) and 327 patients were undergoing peritoneal dialysis (PD). Results: The prevalence of LC was 44 of 1,069 patients (4.1%). The cumulative 1-, 3-, and 5-year survival rates of noncirrhotic patients were 93%, 83%, and 73%, respectively, whereas the equivalent survival rates of cirrhotic patients were 90%, 68%, and 48%, respectively (p = 0.011). After adjustment, LC was an independent risk factor for death in patients with ESRD. No difference in mortality associated with LC was found between the HD and PD subgroups. Conclusions: Of the patients with ESRD, cirrhotic patients had poorer survival than noncirrhotic patients. Among patients with ESRD and LC, survival of patients undergoing PD may be comparable with that of patients undergoing H
참고문헌 (25)
- Collins AJ, "United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States", Am J Kidney Dis, 59(1 Suppl 1), pp.A7~ (2012)
- 진동찬, "Current Status of Dialysis Therapy in Korea", The Korean Journal of Internal Medicine, 26(2), pp.123~131 (2011), 대한내과학회
- Patel PR, "Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients", Am J Kidney Dis, 56, pp.371~378 (2010)
- Edey M, "Review article:hepatitis B and dialysis", Nephrology, 15, pp.137~145 (2010)
- Han YS, "The change of the etiology, complications and cause of death of the liver cirrhosis in 1990s", Korean J Hepatol, 6, pp.328~339 (2000)
- Chien CC, "Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan", BMC Nephrol, 13, pp.43~ (2012)
- Lozano R, "Global and regional mortality from 235 causes of death for 20age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2095~2128 (2012)
- Blachier M, "The burden of liver disease in Europe:a review of available epidemiological data", J Hepatol, 58, pp.593~608 (2013)
- Fede G, "Renal failure and cirrhosis:a systematic review of mortality and prognosis", J Hepatol, 56, pp.810~818 (2012)
- Huang ST, "Outcome of peritoneal dialysis in cirrhotic patients with end-stage renal disease: a 24-years’ experience in Taiwan", Clin Nephrol, 76, pp.306~313 (2011)
- Chaudhary K, "Renal replacement therapy in end-stage renal disease patients with chronic liver disease and ascites: role of peritoneal dialysis", Perit Dial Int, 28, pp.113~117 (2008)
- Chaudhary K, "What is the best chronic dialysis modality for ESRD patients with end-stage liver disease?", Semin Dial, 24, pp.414~415 (2011)
- Pugh RN, "Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
- Hwang SJ, "Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan", Nephrol Dial Transplant, 25, pp.2616~2624 (2010)
- Johnson DW, "Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data", Nephrol Dial Transplant, 24, pp.1598~1603 (2009)
- D’Amico G, "Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies", J Hepatol, 44, pp.217~231 (2006)
- De Vecchi AF, "Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure", Am J Kidney Dis, 40, pp.161~168 (2002)
- Hsiang JC, "Type 2 diabetes:a risk factor for liver mortality and complications in hepatitis B cirrhosis patients", J Gastroenterol Hepatol, 30, pp.591~599 (2015)
- Elkrief L, "Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C", Hepatology, 60, pp.823~831 (2014)
- 김민수, "간경변증이 동반된 말기신부전증환자에서의 신대체 요법", Kidney Research and Clinical Practice, 26(6), pp.705~715 (2007), 대한신장학회
- Marcus RG, "Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites", Am J Med, 93, pp.35~40 (1992)
- Such J, "Spontaneous bacterial peritonitis", Clin Infect Dis, 27, pp.669~674 (1998)
- Martin PY, "Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis", N Engl J Med, 339, pp.533~541 (1998)
- Winney RJ, "Changes in brain water with haemodialysis", Lancet, 2, pp.1107~1108 (1986)
- Donovan JP, "Cerebral oedema and increased intracranial pressure in chronic liver disease", Lancet, 351, pp.719~721 (1998)